Search

Your search keyword '"D. Azria"' showing total 114 results

Search Constraints

Start Over You searched for: Author "D. Azria" Remove constraint Author: "D. Azria" Topic breast neoplasms Remove constraint Topic: breast neoplasms
114 results on '"D. Azria"'

Search Results

1. Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy.

2. (Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer.

3. Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer.

5. [Non-pharmalogical interventions and breast cancer: What benefit in addition to radiotherapy?]

6. Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ.

7. Intraoperative partial irradiation for highly selected patients with breast cancer: Results of the INTRAOBS prospective study.

9. [Treatment of oligometastatic or oligoprogression cancer].

10. [Individual modification of the dose, volume and fractionation of breast radiotherapy].

11. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer.

12. Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity.

13. Magnetic resonance imaging in breast cancer management in the context of neo-adjuvant chemotherapy.

14. [The major debate: Micrometastases and breast cancer - To be for nodal irradiation].

15. Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.

16. [Modalities of breast cancer irradiation in 2016: Aims and indications of intensity modulated radiation therapy].

17. [Breast cancer screening: On our way to the future].

18. [Radiotherapy of breast cancer].

19. Concurrent or sequential letrozole with adjuvant breast radiotherapy: final results of the CO-HO-RT phase II randomized trial.

20. [Perception of pT1a,b pN0 breast tumor prognosis by the French oncology community: Results of the EURISTIC national survey].

21. Comparison of volumetric-modulated arc therapy and dynamic conformal arc treatment planning for cranial stereotactic radiosurgery.

22. [Granulocyte- colony stimulating factor (G-CSF) use in clinical practice in patients receiving chemotherapy for breast cancer: The Opaline Study].

23. Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial.

24. Feasibility of accelerated partial breast irradiation with volumetric-modulated arc therapy in elderly and frail patients.

26. XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients.

27. Patients' satisfaction in early breast cancer treatment: Change in treatment over time and impact of HER2-targeted therapy.

28. [Radiosensitivity settings in breast cancer].

29. [Does nodal irradiation (clavicular and internal mammary chains) increase the toxicity of adjuvant breast radiotherapy?].

30. [Which node area should be irradiated after neoadjuvant chemotherapy in breast cancer?].

31. [Impact of intensity-modulated radiotherapy on node irradiation for breast cancer].

32. Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

33. [New external radiotherapy technologies for breast cancer].

34. [Breast cancer: radiotherapy and estrogen signaling].

35. Rationale for the use of upfront whole brain irradiation in patients with brain metastases from breast cancer.

36. Day-care for breast cancer: ambulatory surgery and intra-operative radiation. Techniques and preliminary results of the Centre Val-d'Aurelle--Montpellier.

37. Resistance to human epidermal growth factor receptor type 2-targeted therapies.

38. Intraoperative radiotherapy for breast cancer.

39. [Partial breast irradiation].

40. [Hypofractionated radiotherapy, a standard in breast cancer?].

41. Prognostic factors of brain metastases from breast cancer: impact of targeted therapies.

42. Electrons for intraoperative radiotherapy in selected breast-cancer patients: late results of the Montpellier phase II trial.

43. Adjuvant radiotherapy in the management of axillary node negative invasive breast cancer: a qualitative systematic review.

44. Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases.

45. [Intensity modulated radiotherapy for breast cancer].

46. Adjuvant early breast cancer systemic therapies according to daily used technologies.

47. [Radiobiology and breast cancer molecular classification: present or future?].

48. [The future of breast cancer radiotherapy: From one size fits all to taylor-made treatment].

49. [Debate: Pro intraoperative radiation therapy in breast cancer].

50. Radiotherapy for invasive breast cancer: guidelines for clinical practice from the French expert review board of Nice/Saint-Paul de Vence.

Catalog

Books, media, physical & digital resources